Myeloid Cells: Orchestrators of Immunity in Health, Disease and Therapy

Jan 01–04, 2027 | Location to be Determined
Scientific Organizers: Julie Helft

  In Person
  On Demand
×

-

Jan 01–04, 2027 | Location to be Determined

Scientific Organizers: Julie Helft

Supported by the  Directors' Fund
Important Deadlines
Early Registration Deadline: Deadlines not yet available for this meeting.
Scholarship Deadline: Deadlines not yet available for this meeting.
Short Talk Abstract Deadline: Deadlines not yet available for this meeting.
Poster Abstract Deadline: Deadlines not yet available for this meeting.
Meeting Summary

Background: myeloid cells include a diverse array of innate sensors, inducers and effectors of immunity.  While a great deal is known about the taxonomy of individual lineages, there is much to learn about the integration of their roles in immunity especially in the context of pathology and immune-directed therapy.

 

Goals and specific aims: this meeting will present a comprehensive and interdisciplinary exploration of myeloid cell biology, encompassing their development, differentiation, and functional roles in health and disease. The program will integrate recent advances in the ontogeny of myeloid cells, their adaptation to microenvironmental and systemic signals, and emerging strategies for therapeutic targeting.

 

Strengths and uniqueness: a key feature of the meeting is its interdisciplinary scope, bringing together basic researchers, clinicians, immunologists, neuroscientists, and infection and cancer biologists.  The major emphasis will be to go ‘beyond lineage’ to focus on the central theme of conceptualizing myeloid cells as systemic immune orchestrators, capable of sensing and responding to disease both locally and in distant tissues. This organism-level perspective will incorporate the spatial and temporal dimensions of myeloid cell biology and disease dynamics. The meeting will explore how this integrative framework may inform novel approaches to immunotherapy across a range of conditions, including neurodegenerative diseases, chronic inflammatory disorders, infection and cancer.

 

The program will be invaluable to researchers seeking new insights into tissue and systemic network interactions with the goals of better understanding human disease or exploiting discoveries in myeloid cell biology for therapeutic advancement.

 

 

Unique Career Development Opportunities

This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives

KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS

Subscribe for Updates